Clinical Trial Update: OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating OT-551 antioxidant eye drops for geographic atrophy in age-related macular degeneration completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• OT-551

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Geographic Atrophy, Age-Related Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2011-07-29